Biología molecular del cáncer
Hospital Duran i Reynals
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (3)
2015
-
First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish cooperative group for the treatment of digestive tumours
European Journal of Cancer, Vol. 51, Núm. 11, pp. 1371-1380
2014
-
TTD consensus document on the diagnosis and management of exocrine pancreatic cancer
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 865-878
2005
-
Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer
Clinical Colorectal Cancer, Vol. 4, Núm. 6, pp. 384-389